首页 | 本学科首页   官方微博 | 高级检索  
检索        

13例早发型腓骨肌萎缩症的基因分型研究
引用本文:徐佳露,章毅,赵聪颖,江佩芳,袁哲锋,余永林,夏哲智,高峰.13例早发型腓骨肌萎缩症的基因分型研究[J].中国当代儿科杂志,2019,21(7):670-675.
作者姓名:徐佳露  章毅  赵聪颖  江佩芳  袁哲锋  余永林  夏哲智  高峰
作者单位:徐佳露, 章毅, 赵聪颖, 江佩芳, 袁哲锋, 余永林, 夏哲智, 高峰
基金项目:国家青年科学基金(81501084)。
摘    要:目的 探讨早发型腓骨肌萎缩症(CMT)的临床特征及遗传变异分析。方法 以临床诊断为早发型CMT的患儿为研究对象,收集相关临床资料,进行肌电图及CMT相关基因检测并分析。结果 早发型CMT病例共13例,男9例(69%),女4例(31%),平均就诊年龄4.0±2.1岁,其中12例(92%)患儿起病年龄 < 2岁。9例(69%)诊断为CMT1型(其中Dejerine-Sottas综合征6人),1例(8%)为中间型,3例(23%)为CMT2型。13例患儿的基因检测结果显示6例(46%)患儿存在外周髓鞘蛋白22(PMP22)基因重复突变、3例(23%)髓鞘蛋白零(MPZ)基因插入突变及点突变、3例(23%)线粒体融合蛋白2(MFN2)基因点突变、1例(8%)人轻肽神经丝蛋白(NEFL)基因点突变,其中11例(85%)为已知致病突变,2例(15%)为新变异。MPZ基因新变异c.394C > G(p.P132A)评级为"可能致病的"及MFN2基因新变异c.326A > G(p.K109R)评级为"致病的"。结论 早发型CMT以PMP22基因重复突变及MPZ基因突变为主,临床分型以CMT1型为主,其中Dejerine-Sottas综合征占有相当比例。

关 键 词:腓骨肌萎缩症  外周髓鞘蛋白22基因  髓鞘蛋白零基因  线粒体融合蛋白2基因  人轻肽神经丝蛋白基因  高通量测序  儿童  
收稿时间:2019-01-09
修稿时间:2019/4/30 0:00:00

A genotyping study of 13 cases of early-onset Charcot-Marie-Tooth disease
XU Jia-Lu,ZHANG Yi,ZHAO Cong-Ying,JIANG Pei-Fang,YUAN Zhe-Feng,YU Yong-Lin,XIA Zhe-Zhi,GAO Feng.A genotyping study of 13 cases of early-onset Charcot-Marie-Tooth disease[J].Chinese Journal of Contemporary Pediatrics,2019,21(7):670-675.
Authors:XU Jia-Lu  ZHANG Yi  ZHAO Cong-Ying  JIANG Pei-Fang  YUAN Zhe-Feng  YU Yong-Lin  XIA Zhe-Zhi  GAO Feng
Institution:XU Jia-Lu, ZHANG Yi, ZHAO Cong-Ying, JIANG Pei-Fang, YUAN Zhe-Feng, YU Yong-Lin, XIA Zhe-Zhi, GAO Feng
Abstract:Objective To study the clinical characteristics and genetic variation of early-onset Charcot-Marie-Tooth disease (CMT). Methods Children with a clinical diagnosis of early-onset CMT were selected for the study. Relevant clinical data were collected, and electromyogram and CMT-related gene detection were performed and analyzed. Results A total of 13 cases of early-onset CMT were enrolled, including 9 males (69%) and 4 females (31%). The mean age at consultation was 4.0±2.1 years. Among them, 12 children (92%) had an age of onset less than 2 years, 9 children (69%) were diagnosed with CMT type 1 (including 6 cases of Dejerine-Sottas syndrome), 1 child (8%) with intermediate form of CMT, and 3 children (23%) with CMT type 2. The genetic test results of these 13 children showed 6 cases (46%) of PMP22 duplication mutation, 3 cases (23%) of MPZ gene insertion mutation and point mutation, 3 cases (23%) of MFN2 gene point mutation, and 1 case (8%) of NEFL gene point mutation. Eleven cases (85%) carried known pathogenic mutations and 2 cases (15%) had novel mutations. The new variant c.394C > G (p.P132A) of the MPZ gene was rated as "possibly pathogenic" and the new variant c.326A > G (p.K109R) of the MFN2 gene was rated as "pathogenic". Conclusions Early-onset CMT is mainly caused by PMP22 gene duplication mutation and MPZ gene mutations. The clinical phenotype is mainly CMT type 1, among which Dejerine-Sottas syndrome accounts for a considerable proportion.
Keywords:

Charcot-Marie-Tooth disease|PMP22 gene|MPZ gene|MFN2 gene|NEFL gene|High-throughput sequencing|Child

点击此处可从《中国当代儿科杂志》浏览原始摘要信息
点击此处可从《中国当代儿科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号